Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Cancer Epigenomics

Bradley Bernstein

布拉德利·伯恩斯坦

MD, PhD

🏢Massachusetts General Hospital / Broad Institute of MIT and Harvard(麻省总医院 / 麻省理工学院与哈佛大学博德研究所)🌐USA

Professor of Pathology; Senior Associate Member, Broad Institute病理学教授;博德研究所高级副研究员

82
h-index
3
Key Papers
4
Awards
3
Key Contributions

👥Biography 个人简介

Bradley Bernstein is a pioneer in cancer epigenomics, renowned for mapping histone modifications and enhancer landscapes in gliomas. His lab discovered how H3K27M mutations rewire the Polycomb epigenome in pediatric glioma and led major contributions to The Cancer Genome Atlas epigenomic profiling efforts.

Share:

🧪Research Fields 研究领域

Cancer Epigenomics癌症表观基因组学
Chromatin Remodeling染色质重塑
Enhancer Reprogramming增强子重编程
Glioma Epigenetics胶质瘤表观遗传学
Cancer Epigenome Atlas癌症表观基因组图谱

🎓Key Contributions 主要贡献

H3K27M Glioma Epigenomics

Elucidated how the H3K27M oncohistone mutation globally redistributes PRC2 activity, driving aberrant gene activation in diffuse intrinsic pontine glioma and providing new therapeutic targets.

Cancer Enhancer Reprogramming

Mapped genome-wide enhancer reprogramming events in glioblastoma stem cells, revealing how transcription factor networks and chromatin accessibility drive tumor plasticity and therapy resistance.

Cancer Epigenome Atlas

Led large-scale epigenomic profiling as part of TCGA and ENCODE consortia, generating reference chromatin state maps across dozens of cancer types that underpin the field.

Representative Works 代表性著作

[1]

H3K27M mutant gliomas reprogram the epigenome via PRC2 inhibition

Nature (2019)

Demonstrated that H3K27M oncohistones trap PRC2 at chromatin, leading to global H3K27me3 loss and focal gain at specific loci driving oncogenesis.

[2]

Epigenomic reprogramming during pancreatic cancer progression

Cell (2017)

Revealed that pancreatic cancer progression involves widespread enhancer remodeling that activates metastatic gene expression programs.

[3]

A chromatin landmark and transcription initiation at most promoters in human cells

Cell (2007)

Foundational study mapping H3K4me3 and H3K27me3 bivalent chromatin domains at developmental gene promoters in human ES cells.

🏆Awards & Recognition 奖项与荣誉

🏆Howard Hughes Medical Institute Investigator
🏆NIH Director's Pioneer Award
🏆American Cancer Society Research Professor
🏆Elected Member, American Society for Clinical Investigation

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 布拉德利·伯恩斯坦 的研究动态

Follow Bradley Bernstein's research updates

留下邮箱,当我们发布与 Bradley Bernstein(Massachusetts General Hospital / Broad Institute of MIT and Harvard)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment